4Arzoo K, Sadeghi S, Liebmao HA. Treatment of refractory aotibody mediated autoimmune disorders with an aoti-CD20 monoclonal aotibody (rituximab). Ann Rheum Dis, 2002, 61: 922-924.
5Keir GJ, Maher TM, Hansell OM, et al. Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy. Eur RespirJ, 2012, 40: 641-648.
6Zaja F, de Vita S, Mazzaro C, et al. Efficacy and safety of rituximah in type Il mixed cryoglobulinemia. Blood, 2003, 10: 3827-3834.
7De Vita S, Quartuccio L, Fahris M. Rituximah in mixed cryoglobulinemia: increased experience and perspectives. Dig Liver Dis, 2007, 39 Suppl 1: 122-128.
8Ferri C, Cacoub P, Mazzaro C. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev, 2011, 11: 48-55.
